SCHEMBL314330

SCHEMBL314330

O=C(Cl)OCC1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9106972 0.86 ALDH1A1 (0.42)
SCHEMBL22657946 0.84 ALDH1A1 (0.52)
SCHEMBL377540 0.80 ALDH1A1 (0.57)
SCHEMBL543862 0.80 ALDH1A1 (0.69)
SCHEMBL1045748 0.79 TP53 (0.74)
SCHEMBL18428568 0.79 TP53 (0.74)
SCHEMBL7772768 0.79 ALDH1A1 (0.67)
SCHEMBL12189491 0.78
SCHEMBL377539 0.78
SCHEMBL12527557 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016149-A2 PROCESS FOR MANUFACTURING GLYCIDOL Solvay (Société Anonyme) (BE) 2009-02-05 WO claimed
EP-3008046-B1 PROCESS FOR THE MANUFACTURE OF EPOXY-MONOMERS AND EPOXIDES SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS (CZ) 2018-08-29 EP disclosed
US-9963436-B2 Process for the manufacture of epoxy-monomers and epoxides SPOLEK PRO CHEMICKOU A HUTNI VYROBU (CZ) 2018-05-08 US disclosed
US-9745273-B2 Phenazine derivatives as anti-neoplastic agents and anti-infective agents UNIVERSITETET I OSLO (NO) 2017-08-29 US disclosed
US-9745273-B2 Phenazine derivatives as anti-neoplastic agents and anti-infective agents UNIVERSITETET I OSLO (NO) 2017-08-29 US disclosed
US-9745273-B2 Phenazine derivatives as anti-neoplastic agents and anti-infective agents UNIVERSITETET I OSLO (NO) 2017-08-29 US disclosed
US-20170166544-A1 PROCESS FOR THE MANUFACTURE OF EPOXY-MONOMERS AND EPOXIDES SPOLEK PRO CHEMICKOU A HUTNI VYROBU A.S. (CZ) 2017-06-15 US disclosed
US-9573917-B2 Process for the manufacture of epoxy-monomers and epoxides SPOLEK PRO CHEMICKOU A HUTNI VYROBU A.S. (CZ) 2017-02-21 US disclosed
EP-3063136-A2 PHENAZINE DERIVATIVES AS ANTI-CANCER AND ANTI-INFECTIVE AGENTS Universitetet I Oslo (NO) 2016-09-07 EP disclosed
US-20160251320-A1 Compounds UNIVERSITÉ CLAUDE BERNARD LYON 1 (FR) 2016-09-01 US disclosed
US-8084553-B2 Curable adhesive compositions, process, and applications TRILLION SCIENCE, INC. (US) 2011-12-27 US disclosed
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES NOTRE DAME UNIVERSITY (US) 2011-09-15 US disclosed
US-7928127-B2 Inhibitors of matrix metallaproteinases NOTRE DAME UNIVERSITY (US) 2011-04-19 US disclosed
CN-101970224-A Curable adhesive compositions, process, and applications TRILLION SCIENCE INC 2011-02-09 CN disclosed
WO-2009089314-A1 CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS TRILLION SCIENCE, INC. (US) 2009-07-16 WO disclosed
US-20090181165-A1 Curable adhesive compositions, Process, and applications TRILLION SCIENCE, INC. (US) 2009-07-16 US disclosed
US-20090181165-A1 Curable adhesive compositions, Process, and applications TRILLION SCIENCE, INC. (US) 2009-07-16 US disclosed
WO-2009016149-A2 PROCESS FOR MANUFACTURING GLYCIDOL Solvay (Société Anonyme) (BE) 2009-02-05 WO disclosed
US-20090005420-A1 Inhibitors of Matrix Metallaproteinases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-01-01 US disclosed
WO-2006125208-A1 INHIBITORS OF MATRIX METALLOPROTEINASES WAYNE STATE UNIVERSITY (US) 2006-11-23 WO disclosed